Recently, we have shown that gefitinib is effective in inhibiting intrahepatic metastasis of murine hepatocellular carcinoma CBO140C12 cells by blocking EGFR-dependent metastatic properties (Matsuo et al, 2003). Here, EGFR is linked to hepatocellular carcinoma.